过去一年中添加的文章，按日期排序
Unveiling the nephrotoxic profile of BCR‐ABL tyrosine kinase inhibitors: A real‐world experience in Africa
ZS Ayalew, GT Azibte, F Tadesse, BA Legesse… - …, 2024 - Wiley Online Library
3 天前 - … inhibitors (TKIs) in treating chronic myelogenous leukemia and other malignancies
is well-… It is used primarily to manage chronic myelogenous leukemia (CML). However, it also …
is well-… It is used primarily to manage chronic myelogenous leukemia (CML). However, it also …
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib
A Leyte-Vidal, RA DeFilippis, IR Outhwaite, I Kwan… - Leukemia, 2024 - nature.com
4 天前 - … newly diagnosed chronic phase chronic myeloid leukemia (CML) patients [1]. In
contrast to previously approved BCR::ABL1 TKIs that target the ATP-binding (“orthosteric”) site, …
contrast to previously approved BCR::ABL1 TKIs that target the ATP-binding (“orthosteric”) site, …
Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis
VA Vardell, J Ose, AV Rets, SK Tantravahi… - … Myeloma and Leukemia, 2024 - Elsevier
4 天前 - … initially included chronic myelomonocytic leukemia (CMML), atypical chronic myeloid
leukemia (aCML), the pediatric disease juvenile myelomonocytic leukemia (JMML), and a …
leukemia (aCML), the pediatric disease juvenile myelomonocytic leukemia (JMML), and a …
Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations
J Gordon, C Bravo-Perez, L Guarnera, S Unlu… - Blood Cancer …, 2024 - nature.com
5 天前 - … selection pressure on affected myeloid leukemic precursors by alleviating the need
for ligand binding [2]. FLT3 MT occurs in about 30% of acute myeloid leukemia (AML) cases, …
for ligand binding [2]. FLT3 MT occurs in about 30% of acute myeloid leukemia (AML) cases, …
Comprehensive Analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, Clinical Features, and Survival Outcomes Based on SEER Database Insights
F Wang - medRxiv, 2024 - medrxiv.org
5 天前 - … The diagnosis of aCML is challenging due to its overlapping features with other
MDS/… such as chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia 19 (…
MDS/… such as chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia 19 (…
[HTML][HTML] SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant
Y Park, S Park, W Chinratanalab, B Savani… - Clinical Hematology …, 2024 - ncbi.nlm.nih.gov
7 天前 - … The patient was a 74-year-old gentleman with intermediate risk acute myeloid
leukemia, who achieved first complete remission (CR1) after treatment with venetoclax/decitabine…
leukemia, who achieved first complete remission (CR1) after treatment with venetoclax/decitabine…
Clonal Hematopoiesis Without Malignant Transformation Lasting Over 2 Years in a 9-Year-old Boy, Following Treatment for Acute Lymphocytic Leukemia
H Yagasaki, K Shimozawa, K Kanezawa… - Journal of Pediatric …, 2024 - journals.lww.com
10 天前 - … with tyrosine kinase inhibitor (TKI) for chronic myeloid leukemia. TKI is not classified
as a … and precede transformation to myeloid leukemia in patients with Fanconi anemia. …
as a … and precede transformation to myeloid leukemia in patients with Fanconi anemia. …
Ubiquitin-specific proteases (USPs) in leukemia: a systematic review
10 天前 - … landscape of leukemia subtypes is dominated by myeloid … myeloid leukemia (AML)
and chronic myeloid leukemia (… leukemia (ALL) and chronic lymphocytic leukemia (CLL) …
and chronic myeloid leukemia (… leukemia (ALL) and chronic lymphocytic leukemia (CLL) …
Einfluss von ASXL1-Mutationen auf das Therapieansprechen bei Patienten mit chronischer myeloischer Leukämie
L Schönfeld - db-thueringen.de
10 天前 - … in newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase,
… next-generation sequencing covering 54 myeloid leukemia associated genes. In total, …
… next-generation sequencing covering 54 myeloid leukemia associated genes. In total, …
Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR
Y Lu, L Lin, J Lin, B Wu, G Cai, X Wang, X Ma - Annals of Hematology, 2024 - Springer
11 天前 - … novo chronic myeloid leukemia (CML) patient with a hidden JAK2 V617F subclone,
which expanded during tyrosine kinase inhibitor (TKI) treatment. … tool for early diagnosis and …
which expanded during tyrosine kinase inhibitor (TKI) treatment. … tool for early diagnosis and …